Abstract
Clinical depression, diagnosed in 5–15% of women during pregnancy, increases the risk of negative pregnancy outcomes including an increased incidence of low birth weight newborns and preterm delivery. Fluoxetine, a selective serotonin reuptake inhibitor, is often prescribed to treat depression due to its efficacy, high margin of safety, and mild side effects. However, fluoxetine initially increases plasma serotonin concentration, and serotonin causes uterine vasoconstriction in sheep, which could result in fetal hypoxemia. To assess fetal fluoxetine effects, late-gestation pregnant sheep were surgically prepared for the measurement of blood gases, heart rate, blood pressure, and uterine artery blood flow (n = 29). Ewes received a 70-mg bolus i.v. infusion of fluoxetine over 2 min in 10 mL of sterile water followed by continuous infusion at a rate of 100 μg/min for 8 d (n = 14), or continuous infusion of sterile water (n = 15). Transient decreases in uterine artery blood flow, fetal Po2, and oxygen saturation were observed within the first 15 min after fluoxetine exposure, which did not return to normal values by 24 h. Fetal pH decreased and Pco2 increased over the first 4 h with a return to normal by 24 h. However, there were no differences in uterine artery blood flow, blood gas status, or cardiovascular measures between the control and fluoxetine group over the rest of the 8-d infusion period. Thus, fluoxetine exposure during pregnancy has transient effects on fetal status that may be of developmental consequence if they occur repetitively.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
Abbreviations
- FX:
-
fluoxetine
- NFX:
-
norfluoxetine
- SSRI:
-
selective serotonin reuptake inhibitor
- UABF:
-
uterine artery blood flow
- sH2O:
-
sterile water
References
Weissman MM, Olfson M 1995 Depression in women: implications for health care research. Science 269: 799–801
Lawrenson RA, Tyrer F, Newson RB, Farmer RDT 2000 The treatment of depression in UK general practice: selective serotonin reuptake inhibitors and tricyclic antidepressants compared. J Affect Disord 59: 149–157
Misri S, Kostaras D, Kostaras X 2000 The use of selective serotonin reuptake inhibitors during pregnancy and lactation: current knowledge. Can J Psychiatry 45: 285–287
Pastuszak A, Schick-Boschetto B, Zuber C, FM Pinelli M, Sihn S, Donnenfeld A, McCormack M, Leen-Mitchell M, Woodland C, Gardner A, Hom M, Koren G 1993 Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 269: 2246–2248
Addis A, Koren G 2000 Safety of fluoxetine during the first trimester of pregnancy: a meta-analytical review of epidemiological studies. Psychol Med 30: 89–94
Chambers CD, Johnson KA, Dick LM, Felix RJ, Jones KL 1996 Birth outcomes in pregnant women taking FX. N Engl J Med 335: 1010–1015
Goldstein DJ 1995 Effects of third trimester fluoxetine exposure on the newborn. J Clin Psychopharmacol 15: 417–420
Nulman I, Rovet J, Stewart D, Wopin J, Gardner HA, Theis JGW, Kulin N, Koren G 1997 Neurodevelopment of children exposed in uteroto antidepressant drugs. N Engl J Med 336: 258–262
Blier P, de Montigny C 1998 Possible serotonergic mechanisms underlying the antidepressant and anti-obsessive-compulsive disorder responses. Biol Psychiatry 44: 313–323
Karlsson C, Bodelsson G, Bodelsson M, Stjernquist M 1999 Characterisation of 5-hydroxytryptamin receptors mediating circular smooth muscle contraction in the human umbilical artery. Gynecol Obstet Invest 47: 102–107
Berman W, Goodlin RC, Heyman MA, Rudolph AM 1978 Effects of pharmacologic agents on umbilical blood flow in fetal lambs in utero. Biol Neonate 33: 225–235
Clark KE, Mills EG, Otte TE, Stys SJ 1980 Effect of serotonin on UABF in pregnant and nonpregnant sheep. Life Sci 27: 2655–2661
Rurak DW, Yoo SD, Kwan E, Taylor SM, Riggs KW, Axelson JE 1988 Effects of diphenhydramine in the fetal lamb after maternal or fetal administration. J Pharmacol Exp Ther 247: 271–278
Kim J, Axelson JE, Kearns GL, Yin W, Rurak DW 1995 Stereoselective determination of fluoxetine and norfluoxetine with mass-selective detection (GC/MSD). Pharm Res 12: S22
Benfield P, Heel RC, Lewis SP 1986 Fluoxetine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 32: 481–508
Kim J, Misri S, Kent N, Oberlander T, Rurak DW, Riggs KW 1999 Comparison of fetal and neonatal fluoxetine and paroxetine exposure during the perinatal period in humans. AAPS PharmSci 1: S96
Lemberger L, Bergstrom RF, Wolen RL, Farid NA, Enas GG, Aronoff GR 1985 Fluoxetine: clinical pharmacology and physiologic disposition. J Clin Psychiatry 46: 14–19
Hiemke C, Härtter S 2000 Pharmacokinetics of selective serotonin reuptake inhibitors. Pharmacol Ther 85: 11–28
Yaffe H, Parer JT, Block BS, Llanos AJ 1987 Cardiorespiratory responses to graded reductions of UABF in the sheep fetus. J Dev Physiol 9: 325–336
Giussani DA, Unno N, Jenkins SL, Wentworth RA, Derks JB, Collins JH, Nathanielsz PW 1997 Dynamics of cardiovascular responses to repeated partial umbilical cord compression in late-gestation sheep fetus. Am J Physiol 273: H2351–H2360
Ortiz J, Artigas F 1992 Effects of monoamine uptake inhibitors on extracellular and platelet 5-hydroxytryptamine in rat blood: different effects of clomipramine and fluoxetine. J Pharmacol 105: 941–946
Llanos AJ, Court DJ, Block BS, Germain AM, Parer JT 1986 Fetal cardiorespiratory changes during spontaneous prelabor uterine contraction in sheep. Am J Obstet Gynecol 155: 893–897
Slater JS, Mellor DJ 1981 Within-day variations in the composition of maternal and fetal plasma from catheterised ewes fed once daily or at hourly intervals during late pregnancy. Res Vet Sci 31: 224–230
Towell ME, Figueroa J, Markowitz S, Elias B, Nathanielsz P 1987 The effect of mild hypoxemia maintained for twenty-four hours on maternal and fetal glucose, lactate, cortisol, and arginine vasopressin in pregnant sheep at 122 to 139 days' gestation. Am J Obstet Gynecol 157: 1550–1557
Bocking AD, Challis JRG, White SE 1991 Effect of acutely-induced lactic acidemia on fetal breathing movements, heart rate, blood pressure, ACTH and cortisol in sheep. J Dev Physiol 16: 45–50
Alvarez JC, Gluck N, Arnulf I, Quintin P, Leboyer M, Pexquery R, Launay JM, Perez-Diaz F, Spreux-Varoquaux O 1999 Decreased platelet serotonin transporter sites and increased platelet inositol triphosphate levels in patients with unipolar depression: effects of clomipramine and fluoxetine. Clin Pharmacol Ther 66: 617–624
Alvarez JC, Sanceaume M, Advenir C, Spreux-Varoquaux O 1999 Differential changes in brain and platelet 5-HT concentrations after steady-state achievement and repeated administration of antidepressant drugs in mice. Eur Neuropsychopharmacol 10: 31–36
Hedriana HL, Brace RA, Gilbert WM 1995 Changes in blood flow to the ovine chorion and amnion across gestation. J Soc Gynecol Investig 2: 727–734
Bell AW, Kennaugh JM, Battaglia FC, Makowski EL 1986 Metabolic and circulatory studies of fetal lambs at midgestation. Am J Physiol 250: E538–E544
Boddy K, Dawes GS, Fisher R, Pinter S, Robinson JS 1974 Foetal respiratory movements, electrocortical and cardiovascular responses to hypoxaemia and hypercapnia in sheep. J Physiol 243: 599–618
Tan W 1997 Circulatory and metabolic studies of normally grown and growth restricted fetal sheep before and during spontaneous labor and delivery. PhD thesis, University of British Columbia, Vancouver, British Columbia, Canada, 154–160
Cohen LS, Heller VL, Bailey JW, Grush L, Ablon JS Bouffard SM 2000 Birth outcomes following perinatal exposure to fluoxetine. Biol Psychiatry 48: 996–1000
Shinozuka N, Nathanielsz PW 2000 Increased myometrial contracture frequency at 96 to 140 days gestation (dGA) accelerates high voltage (HV)/low voltage (LV) electrocorticgram cyclicity maturation in fetal sheep. J Soc Gynecol Investig 7: 108A
Shinozuka N, Yen A, Nathanielsz PW 1999 Alteration of fetal oxygenation and responses to acute hypoxemia by increased myometrial contracture frequency produced by pulse administration of oxytocin to the pregnant ewe from 96–131 days' gestation. Am J Obstet Gynecol 180: 1202–1
Acknowledgements
The authors thank Novopharm (Toronto, ON, Canada) for the generous donation of fluoxetine hydrochloride.
Author information
Authors and Affiliations
Corresponding author
Additional information
Funding for this research was provided by the Canadian Institutes of Health Research (CIHR). D.R. is a recipient of an investigatorship award from the British Columbia Research Institute for Children's & Women's Health. J.L.M. is a recipient of a CIHR studentship award. C.C. is a recipient of a PMAC/HRF-CIHR studentship award.
Rights and permissions
About this article
Cite this article
Morrison, J., Chien, C., Riggs, K. et al. Effect of Maternal Fluoxetine Administration on Uterine Blood Flow, Fetal Blood Gas Status, and Growth. Pediatr Res 51, 433–442 (2002). https://doi.org/10.1203/00006450-200204000-00007
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1203/00006450-200204000-00007
This article is cited by
-
The Serotonergic System and Bone Metabolism During Pregnancy and Lactation and the Implications of SSRI Use on the Maternal-Offspring Dyad
Journal of Mammary Gland Biology and Neoplasia (2023)
-
Postnatal outcomes in lambs exposed antenatally and acutely postnatally to fluoxetine
Pediatric Research (2019)
-
Feasibility of detecting myocardial infarction in the sheep fetus using late gadolinium enhancement CMR imaging
Journal of Cardiovascular Magnetic Resonance (2016)
